research

At the Technion- Israel Institute of Technology, my research group is developing biomimetic nanoparticles (NP) to treat neurodegenerative pediatric diseases, traumatic brain injuries, and breast and ovarian cancers. Our lab's main goal is to be one of the world's leading research groups in developing targeted biomimetic NP that can encapsulate a wide range of therapeutic molecules, including mRNA, proteins, and small molecules, thus revolutionizing how we treat numerous diseases.

Biomimicry

Synthesis of biomimetic nanoparticles to target and treat inflammation, cancer, neurodegenerative and cardiovascular diseases.

cancer treatment and detection

Developing drug delivery system for the sustained release of genetic cargo, proteins, and small molecules.

infant therapy and oral Drug delivery

We seek to explore and understand natural biological processes that occur during childhood with the goal of applying this knowledge to treat infants in a new way.

nervous system targeted delivery

Developing delivery strategies to transport therapeutics to the nervous system, aiming to treat neurological disorders, enhance regeneration, or modulate neural activity.

Protein corona

Exploring Nanoparticles Protein Corona

Anchor 1